J7203 HCPCS Level II code: Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
J7203 is the HCPCS code for “Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
Short description: Factor ix recomb gly rebinyn
HCPCS · United States
Medicare details
The indicators CMS publishes with J7203 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J7203 sits
- 1J codesDrugs administered other than orally
- 2Active code J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7203 mean?
J7203 is the HCPCS code for “Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7203?
CMS lists J7203’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7203
All J codesJ7197Antithrombin iii (human), per i.u.J7198Anti-inhibitor, per i.u.J7199Hemophilia clotting factor, not otherwise classifiedJ7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iuJ7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.J7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iuJ7205Injection, factor viii fc fusion protein (recombinant), per iuJ7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.